首页 > 市场调查报告书 > 医疗设备

体外诊断

病毒携带者筛检市场规模、份额和成长分析（按检测类型、疾病类型、医疗状况、技术、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898499

病毒携带者筛检市场规模、份额和成长分析（按检测类型、疾病类型、医疗状况、技术、最终用户和地区划分）－2026-2033年产业预测

Carrier Screening Market Size, Share, and Growth Analysis, By Test Type (Molecular Screening Test, Biochemical Screening Test), By Disease Type, By Medical Condition, By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 177 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球病毒携带者筛检市场规模预计在 2024 年达到 28.3 亿美元，从 2025 年的 32 亿美元成长到 2033 年的 86.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 13.2%。

市场分析显示，遗传疾病发生率的上升以及人们对预防医学日益增长的兴趣是推动全球携带者筛检需求的关键因素。基因组技术的创新以及人们对囊肿纤维化、戴-萨克斯病和镰状细胞贫血等遗传疾病认识的提高，预计将推动携带者筛检的广泛应用。此外，基因检测的普及和有利的报销政策有望为该领域的公司创造巨大的机会。然而，缺乏标准化、发展中地区认知度低、结果解读复杂以及先进携带者筛检技术高成本等挑战，可能会对市场成长构成重大障碍，并影响携带者筛检解决方案的整体前景。

全球载体筛检市场驱动因素

全球遗传疾病发病率的不断上升，以及人们对这些疾病的认知日益提高，预计将显着推动对携带者筛检服务的需求。此筛检旨在帮助高风险族群和夫妇做出知情的生育决定，最终最大限度地降低将囊肿纤维化、戴-萨克斯病和镰状细胞贫血等遗传疾病传给后代的风险。随着越来越多的人意识到携带者筛检在遗传风险管理方面的益处，预计该服务的市场将会成长，这反映出人们对遗传健康和计划生育选择的理解不断加深。

限制全球载体筛检市场的因素

由于缺乏标准化的携带者筛检指南和法规，不同应用情境的筛检结果差异很大。这种不一致给寻求可靠、准确筛检方案的医疗服务提供者和患者带来了巨大挑战。因此，缺乏统一性会削弱人们对携带者筛检方法的信任，阻碍其在临床环境中的广泛应用。缺乏既定标准可能会使医疗服务提供者和患者对采用这些筛检望而却步，最终影响全球携带者筛检市场的未来发展和成长。制定一致可靠的指南对于增强人们对这些重要筛检工具的信心至关重要。

全球载体筛检市场趋势

全球携带者筛检市场正呈现与数位医疗日益融合的显着趋势，这正在重塑企业的营运方式以及与患者的互动模式。透过整合先进的数位解决方案，携带者筛检提供者正在提升患者的便利性和参与度，使筛检流程更加便捷易用。这种无缝整合不仅简化了营运流程，还提高了人们对携带者筛检的认知度和接受度，最终推动了业务成长。随着医疗保健产业的不断发展，数位化工具的应用预计将在扩大携带者筛检服务的全球覆盖范围和影响力方面发挥关键作用。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Illumina, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
Natera, Inc.（USA）
Myriad Genetics, Inc.（USA）
Eurofins Scientific（Luxembourg）
Laboratory Corporation of America Holdings（LabCorp）（USA）
Quest Diagnostics Incorporated（USA）
Invitae Corporation（USA）
PerkinElmer, Inc.（USA）
Fulgent Genetics（USA）
Agilent Technologies, Inc.（USA）
Genomics England（UK）
Centogene AG（Germany）
Integrated DNA Technologies, Inc.（IDT）（USA）
BGI Genomics（China）
Ambry Genetics Corporation（USA）
DNA Genotek Inc.（Canada）
GeneDx, Inc.（USA）
MedGenome Labs Pvt. Ltd.（India）

结论与建议

简介目录

Product Code: SQMIG35A2993

Global Carrier Screening Market size was valued at USD 2.83 Billion in 2024 and is poised to grow from USD 3.2 Billion in 2025 to USD 8.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period (2026-2033).

Market insights indicate that the growing prevalence of genetic diseases and the increasing focus on preventive healthcare are key factors propelling the demand for carrier screening globally. Innovations in genomic technologies and heightened awareness of genetic disorders, such as cystic fibrosis, Tay-Sachs, and sickle cell anemia, are expected to enhance the uptake of carrier screening. Additionally, improved accessibility to genetic testing and favorable reimbursement policies are anticipated to create significant opportunities for companies in this sector. However, challenges such as the lack of standardization, limited awareness in developing regions, complexities in result interpretation, and high costs associated with advanced carrier screening technologies pose considerable obstacles to market growth and may impact the overall outlook for carrier screening solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Carrier Screening Market Segments Analysis

Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Carrier Screening Market

The rising occurrence of genetic disorders globally, coupled with heightened awareness about these conditions, is expected to significantly drive the demand for carrier screening services. This form of screening empowers individuals and couples who may be at risk to make informed decisions regarding reproduction, ultimately aiming to minimize the likelihood of passing on hereditary conditions such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia. As more people recognize the benefits of carrier screening in managing genetic risks, the market for these services is anticipated to grow, reflecting a broader understanding of genetic health and family planning options.

Restraints in the Global Carrier Screening Market

The absence of standardized guidelines or regulations for carrier screening panels leads to variability in results among different applications. This inconsistency poses significant challenges for healthcare providers and patients who seek reliable and accurate screening solutions. As a result, the lack of uniformity undermines the trust in carrier screening methods, hindering their widespread acceptance and utilization in clinical practice. Without established standards, both providers and patients may hesitate to embrace these screenings, which ultimately affects future advancements and the growth of the global carrier screening market. Consistent, reliable guidelines are essential to foster confidence in the adoption of these critical screening tools.

Market Trends of the Global Carrier Screening Market

The Global Carrier Screening market is increasingly witnessing a trend toward digital health integration, which is reshaping how companies operate and engage with patients. By incorporating advanced digital solutions, carrier screening providers enhance patient convenience and engagement, making the screening process more accessible and user-friendly. This seamless integration not only streamlines workflows but also fosters awareness and uptake among individuals considering carrier screening, ultimately driving business growth. As healthcare continues to evolve, the adoption of digital tools is expected to play a pivotal role in expanding the reach and impact of carrier screening services globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Carrier Screening Market Size by Test Type & CAGR (2026-2033)

Market Overview
Molecular Screening Test
Biochemical Screening Test

Global Carrier Screening Market Size by Disease Type & CAGR (2026-2033)

Market Overview
Cystic Fibrosis
Tay-Sachs
Gaucher Disease
Sickle Cell Disease
Spinal Muscular Atrophy
Other Autosomal Recessive Genetic Disorders

Global Carrier Screening Market Size by Medical Condition & CAGR (2026-2033)

Market Overview
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others

Global Carrier Screening Market Size by Technology & CAGR (2026-2033)

Market Overview
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others

Global Carrier Screening Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Reference Laboratories
Physician Offices and Clinics
Others

Global Carrier Screening Market Size & CAGR (2026-2033)

North America (Test Type, Disease Type, Medical Condition, Technology, End User)
- US
- Canada
Europe (Test Type, Disease Type, Medical Condition, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Disease Type, Medical Condition, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Disease Type, Medical Condition, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Disease Type, Medical Condition, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fulgent Genetics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomics England (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Centogene AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (IDT) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambry Genetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNA Genotek Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneDx, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedGenome Labs Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments